Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gump, J.
Right arrow Articles by Koh, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gump, J.
Right arrow Articles by Koh, J.
[Cancer Research 61, 3863-3868, May 15, 2001]
© 2001 American Association for Cancer Research


Advances in Brief

The COOH Terminus of p18INK4C Distinguishes Function from p16INK4A1

Jay Gump, Saralinda Turner and James Koh2

Departments of Molecular Physiology and Biophysics [J. G.], Pathology [S. T., J. K.], and Medicine [J. K.], University of Vermont, Burlington, Vermont 05405

The INK4 family of proteins consists of four members which can block progression from the G1-to-S phase of the cell cycle by inhibiting the activity of cyclin dependent kinases (cdks) 4 and 6. Although the gene encoding p16INK4a is commonly inactivated in human tumors, p18INK4c is rarely altered. We show here that overexpression of p18INK4c does not block cell cycle progression in a T-cell acute lymphocytic leukemia cell line (CEM) sensitive to p16INK4a-mediated G1 arrest. A chimera consisting of the kinase-binding region of p16INK4a fused to the COOH terminus of p18INK4c is active in all known biochemical assays for INK4 function, but it does not arrest CEM cells. These data imply a novel level of p18INK4c regulation mediated through the COOH terminus and suggest that functional differences might underlie the distinct mutational profiles observed for p16INK4a and p18INK4c in tumors.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.